Acadian Asset Management
TPST icon

Acadian Asset Management’s Tempest Therapeutics TPST Stock Holding History

Acadian Asset Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-665
Closed -$96K – 2014
2021
Q2 		$96K Sell
665
-828
-55% -$186K ﹤0.01% 1642
2021
Q1 		$350K Buy
1,493
+978
+190% +$395K ﹤0.01% 1316
2020
Q4 		$215K Buy
515
+5
+1% +$1.73K ﹤0.01% 1527
2020
Q3 		$162K Sell
510
-787
-61% -$267K ﹤0.01% 1527
2020
Q2 		$445K Buy
+1,297
New +$517K ﹤0.01% 1232

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Acadian Asset Management's TPST Position: Q3 2021 in Review

Acadian Asset Management sold out of Tempest Therapeutics (TPST) in Q3 2021, closing a stake of 665 shares — an estimated $96K sold.

Acadian Asset Management first reported a position in TPST in Q2 2020 and held it in 5 quarters. The position peaked at $445K in Q2 2020. 20 funds tracked by Wall St. Rank hold TPST as of Q3 2021.

  • Acadian Asset Management reported no remaining Tempest Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 665 Tempest Therapeutics shares in Q3 2021, an estimated $96K.
  • Acadian Asset Management first reported a position in Tempest Therapeutics in Q2 2020 and held it in 5 quarters.
  • Acadian Asset Management's Tempest Therapeutics position peaked at $445K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.